SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-272314
Filing Date
2014-07-18
Accepted
2014-07-18 08:10:01
Documents
7
Period of Report
2014-07-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d761372d8k.htm 8-K 19943
2 EX-99.1 d761372dex991.htm EX-99.1 20827
3 EX-99.2 d761372dex992.htm EX-99.2 13926
4 GRAPHIC g761372ex99_2s1gbgd.jpg GRAPHIC 29029
5 GRAPHIC g761372ex99_2s2gbgd.jpg GRAPHIC 28748
6 GRAPHIC g761372img001.jpg GRAPHIC 12044
7 GRAPHIC g761372img002.jpg GRAPHIC 8187
  Complete submission text file 0001193125-14-272314.txt   164146
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 14981720
SIC: 2834 Pharmaceutical Preparations